Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods

被引:11
作者
Khayat, R
Batra, R
Bebernitz, GA
Olson, MW
Tong, L [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[2] Wyeth Discovery Res, Pearl River, NY 10965 USA
关键词
D O I
10.1021/bi035170d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Herpesviruses encode a serine protease that is essential for the maturation of infectious virions. This protease has a unique polypeptide backbone fold and contains a novel Ser-His-His catalytic triad. It exists in a monomer-dimer equilibrium in solution, but only the dimer form of the enzyme is catalytically active. The stability of this dimer is affected by the presence of anti-chaotropic agents. Most of the reported K-d values for this dimer (between 0.6 and 6 muM) are inconsistent with the fact that the protease is routinely assayed at 20-50 nM concentrations, as only monomeric species would be expected with such K-d values. We have characterized the monomer-dimer equilibrium of HCMV protease using a new method, which observes the exchange between dimers of the wild-type enzyme and the active-site Ser132A1a mutant in a titration experiment. The K-d of the dimer was determined to be 8 muM and 31 nM in the absence or presence of anti-chaotropic agents (10% glycerol and 0.5 M Na2SO4), respectively. Detailed kinetic analysis also showed that, in addition to the 260-fold stabilization of the dimer, the anti-chaotropic agents produced a 7-fold enhancement in the catalytic activity of the dimer.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 33 条
  • [1] Structural studies of herpesvirus proteases
    Batra, R
    Khayat, R
    Tong, L
    [J]. PROTEIN AND PEPTIDE LETTERS, 2001, 8 (05) : 333 - 342
  • [2] Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease
    Batra, R
    Khayat, R
    Tong, L
    [J]. NATURE STRUCTURAL BIOLOGY, 2001, 8 (09) : 810 - 817
  • [3] Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors
    Bonneau, PR
    GrandMaitre, C
    Greenwood, DJ
    Lagace, L
    LaPlante, SR
    Massariol, MJ
    Ogilvie, WW
    OMeara, JA
    Kawai, SH
    [J]. BIOCHEMISTRY, 1997, 36 (41) : 12644 - 12652
  • [4] Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies
    Bonneau, PR
    Plouffe, C
    Pelletier, A
    Wernic, D
    Poupart, MA
    [J]. ANALYTICAL BIOCHEMISTRY, 1998, 255 (01) : 59 - 65
  • [5] RIBBON MODELS OF MACROMOLECULES
    CARSON, M
    [J]. JOURNAL OF MOLECULAR GRAPHICS, 1987, 5 (02): : 103 - &
  • [6] Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad
    Chen, P
    Tsuge, H
    Almassy, RJ
    Gribskov, CL
    Katoh, S
    Vanderpool, DL
    Margosiak, SA
    Pinko, C
    Matthews, DA
    Kan, CC
    [J]. CELL, 1996, 86 (05) : 835 - 843
  • [7] Characterization of human cytomegalovirus protease dimerization by analytical centrifugation
    Cole, JL
    [J]. BIOCHEMISTRY, 1996, 35 (48) : 15601 - 15610
  • [8] Active human cytomegalovirus protease is a dimer
    Darke, PL
    Cole, JL
    Waxman, L
    Hall, DL
    Sardana, MK
    Kuo, LC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) : 7445 - 7449
  • [9] Gibson Wade, 1995, Perspectives in Drug Discovery and Design, V2, P413, DOI 10.1007/BF02172034
  • [10] ACTIVATION OF THE HERPES-SIMPLEX VIRUS TYPE-1 PROTEASE
    HALL, DL
    DARKE, PL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (39) : 22697 - 22700